SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 6 — Focused Visit (Care-plan review) — Phillis Wheatley — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientPhillis Wheatley
Date of birth1753-07-01
IdentifiersMRN HR-EN015-SYN-TD; SSN (made up) 000-15-3360
Document date1773-10-26
AuthorAbena Hartley-Okonkwo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Asthma review five weeks after an exacerbation with a cold. [S]

History of Present Illness

Miss Wheatley returns five weeks after the sick visit for asthma with a cold, when she stepped up to budesonide-formoterol as maintenance and reliever. The nurse telephoned her two days later and she was improving; she did not come for the review booked within a week, because she was very busy after her return. She never needed the standby prednisone. Her cold cleared within ten days; she now takes one inhalation twice daily and needs an extra one about once a week, and has not woken at night for three weeks. Her peak flow is 370 to 390 L/min. The screening tests from her preventive visit were negative for HIV, hepatitis C and hepatitis B surface antigen, and she has no immunity to hepatitis B. She has news she wanted to share: she now holds her own papers and her freedom, and whatever she earns from her book is her own. For now she still lives in the same house. [S]

ElementDetail
ControlAsthma Control Test 20; extra reliever about once a week; no night waking for three weeks
After the exacerbationNurse call on day two; review within a week missed; no oral corticosteroid needed
Screening resultsHIV, hepatitis C antibody and hepatitis B surface antigen negative; hepatitis B surface antibody negative
CircumstancesNow free, with her own papers and her own earnings

Review of Systems

SystemResultFinding
RespiratoryNegativeNo night waking; extra reliever about once a week
Ears, nose, mouth, and throatNegativeCold resolved; no hoarseness or thrush
ConstitutionalNegativeEnergy back; weight 47.6 kg
PsychiatricNegativeHopeful and busy; PHQ-2 0

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Budesonide-formoterol 160/4.5 mcg inhaler as needed only (GINA track 1, step 2, anti-inflammatory reliever): one inhalation whenever needed for symptoms or before exercise in the cold, no more than 12 inhalations a dayOne inhalation as neededRespiratory tract route1773-02-23 to 1773-09-21completedS
Prednisone 20 mg oral tablet, standby course for the sea journey and the summer away: two tablets (40 mg) each morning for five days, to start only as her action plan directs40 mg each morning for five days if the action plan directsOral route1773-04-06 to 1773-10-26stoppedS
Meclizine 25 mg oral tablet, one tablet an hour before sailing and then once daily as needed for seasicknessOne tablet daily as needed at seaOral route1773-04-06 to 1773-09-21completedS
Folic acid 0.4 mg oral tablet, one tablet dailyOne tablet dailyOral route1773-04-27activeS
Budesonide-formoterol 160/4.5 mcg inhaler as maintenance and reliever (GINA track 1, step 3): one inhalation twice daily and one inhalation as needed, no more than 12 inhalations a dayOne inhalation twice daily plus one as neededRespiratory tract route1773-09-21activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1773-10-26Body height152cmS
1773-10-26Body weight47.6kgS
1773-10-26Body mass index (BMI) [Ratio]20.6kg/m2S
1773-10-26Systolic blood pressure104mm[Hg]S
1773-10-26Diastolic blood pressure66mm[Hg]S
1773-10-26Heart rate74/minS
1773-10-26Respiratory rate14/minS
1773-10-26Body temperature36.5CelS
1773-10-26Oxygen saturation in Arterial blood by Pulse oximetry99%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1773-10-26Total score [ACT]20{score}S
1773-10-26FEV1 --pre bronchodilation2.45LLower limit of normal; predicted 2.70 L; lower limit of normal 2.17 L (GLI Global race-neutral equations)NormalS
1773-10-26FEV1 measured/predicted91%GLI Global race-neutral equationsNormalS
1773-10-26FEV1/FVC0.78{ratio}Lower limit of normal for her age (GLI Global)NormalS
1773-10-26Fractional concentration of exhaled nitric oxide24[ppb]Above 50 ppb high; 25 to 50 intermediate (ATS)NormalS
1773-10-26Maximum expiratory gas flow Respiratory system airway by Peak flow meter385L/min80 percent of her personal best of 400 L/minNormalS
1773-10-26Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S

Physical Exam

Vital signs recorded on 1773-10-26; see the Vital Signs section. [S]

SystemFinding
GeneralWell; oxygen saturation 99 percent; peak flow 385 L/min
Head, eyes, ears, nose, and throatNo oral thrush
RespiratoryClear
Inhaler techniqueCorrect with the spacer

Problems

ProblemClinical statusVerificationCodeProvenance
Wheeze, cough and breathlessness this winter, for about three months: symptoms on three or four days a week, waking with cough and a tight chest about twice a month, breathless climbing the hill streets in cold air; worse with cold wind, kitchen and fireplace smoke, and colds; called a weak chest and asthma since childhood but never tested or treated. Asthma to be confirmed with spirometry before and after bronchodilator and FeNOresolvedconfirmed R06.2S — Synthetic presenting problem anchored to her documented frail, asthmatic childhood. Superseded by the diagnosis at the second visit.
Asthma, confirmed, mild persistent: variable airflow obstruction (FEV1/FVC 0.72, below the lower limit of normal, rising to 0.80 after bronchodilator; FEV1 2.24 L, 83 percent predicted, rising 330 mL or 15 percent); type 2 inflammation (FeNO 38 ppb, blood eosinophils 0.38 x10^3/uL, total IgE 165, house dust mite sensitization); tuberculosis infection test negative and chest X-ray clear. Triggers: cold air, kitchen and fireplace smoke, coldsactiveconfirmed J45.30S — Synthetic modern confirmation linked to her documented frail, asthmatic childhood and her own later descriptions of asthma.
Asthma exacerbation with a cold a week after returning from abroad: three days of wheeze, chest tightness and waking at night despite six to eight reliever inhalations a day; peak flow 270 L/min (68 percent of her best of 400), oxygen saturation 96 percent; 330 L/min after treatment in clinic; treated without oral corticosteroids; resolvedresolvedconfirmed J45.31S — Synthetic exacerbation anchored to her own letter describing a cold and asthma after her return; the clinical details are synthetic.
Prone to seasickness on boat trips; meclizine for the sea crossing; resolved on her returnresolvedconfirmed T75.3XXAS — Synthetic travel-related problem.
Pregnancy planning: not sexually active and no contraception wanted now; she may wish to have children one day; folic acid by her choice, and asthma care planned before and during any pregnancyactiveconfirmed Z31.69S — Synthetic reproductive health counselling; not a claim about her real life.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyAsthma Control Test, symptoms, night waking and reliever useEvery visitCompleted todayAsthma Control Test 20; extra reliever about once a week; no night waking
ImagingSpirometry and FeNOThree to six months after starting treatment and after an exacerbationCompleted todayFEV1 2.45 L (91 percent); FEV1/FVC 0.78; FeNO 24 ppb
ImagingPeak flowEvery visit and at homeCompleted today385 L/min, green zone
ExaminationInhaler technique with her own inhaler, and adherenceEvery visit; before any step-upCompleted todayCorrect with the spacer; maintenance doses taken by the dose counter
Self-managementWritten asthma action planEvery visit and after every exacerbationCompleted todayUpdated for maintenance and reliever through the winter
Self-managementExacerbation history (oral corticosteroid courses, emergency visits, admissions)Every visitCompleted todayOne exacerbation in the past year, with a cold, managed without an oral corticosteroid or emergency care
Self-managementReview within a week of an exacerbationWithin one to seven days after any exacerbationDeferredMissed: the nurse telephoned on day two, but she did not attend the review booked within a week because she was busy after her return. No harm resulted: she recovered without an oral corticosteroid and her lung function is normal today. Corrective action: the clinic now offers a telephone or video review on the fifth to seventh day when an in-person visit is not kept, and she agreed to that for any future exacerbation
Self-managementStep-up or step-down assessment (GINA track 1)Every visitCompleted todayStepped to step 3 maintenance and reliever after the exacerbation; continue through the winter; step-down in the spring
Self-managementTriggers, exposures and smoking or vapingEvery visitCompleted todayColds and cold, damp air; kitchen fan and open window; no smoke exposure
SurveyDepression screenYearly and when circumstances changeCompleted todayPHQ-2 0
Self-managementVaccinationsYearlyCompleted todayInfluenza and COVID-19 for the new season; hepatitis B series completed; HPV dose 2 of 3
ReferralBiologic assessmentWhen asthma is severe or uncontrolled despite optimized step 4 to 5 treatmentNot indicatedMild asthma controlled at step 3
Self-managementPrivate conversation: consent, safety and exploitation, and her own decisionsEvery visitCompleted todaySeen alone; she reports her freedom; social work booked at her request

Goal progress:

Immunizations given today: Hepatitis B vaccine (HepB-CpG), dose 2 of 2; Human papillomavirus vaccine (9-valent), dose 2 of 3; Influenza vaccine, the new season; COVID-19 mRNA vaccine, the new season's formula [S]

Guideline basis: CMID: Clinical Monitoring Intelligence Database, asthma monograph (2026); Global Strategy for Asthma Management and Prevention, 2025 update (2025); 2020 Focused Updates to the Asthma Management Guidelines: A Report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group (2020); Bhakta NR, et al. Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement. Am J Respir Crit Care Med 2023;207(8):978-995 (PMID 36973004) (2023); Adult Immunization Schedule by Age (2026)

Follow-up: Asthma review in three months, sooner in the yellow zone. HPV dose 3 in about three months. Social work appointment next week. Preventive visit in the spring. [S]